UnitedHealth Group has reached a deal to sell its South American healthcare business, Banmedica, to the private equity firm Patria Investments for a substantial $1 billion. This strategic move marks a significant step in the company's turnaround efforts, led by CEO Stephen Hemsley, who returned to the helm in May after a challenging period. The sale of Banmedica, which operates in Colombia and Chile, has been a long-standing discussion, with UnitedHealth aiming to exit Latin America since 2022. This exit further streamlines UnitedHealth's focus on its core business, reducing distractions and accelerating its growth trajectory. With a renewed emphasis on profitability, UnitedHealth raised its annual profit forecast in October, targeting a return to growth in 2026, which is expected to gain momentum in 2027. The sale comes after a turbulent time for the company, including a high-profile murder of a top executive, an unexpected surge in medical costs, and a federal probe. Hemsley's leadership has been pivotal in rebuilding investor and consumer trust, ensuring a more stable future for the company.
